| Inventor | Institute |
|---|---|
| Bernhard B. Singer | LeukoCom |
| Cat. #: | 153999 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology |
| Application: | ELISA ; FACS ; WB |
| Target: | Human CEACAM 21 |
| Reactivity: | Human |
| Host: | Mouse |
| Class: | Monoclonal |
| Conjugation: | Unconjugated |
|---|---|
| Isotype: | IgG1 kappa |
| Immunogen: | Recombinant soluble human CEACAM 21-Fc produced in HEK293 Transfectants |
| Myeloma used: | NS1/0 |
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Tchoupa et al. 2014. Cell Commun Signal. 12:27. PMID: 24735478. Signaling by epithelial members of the CEACAM family – mucosal docking sites for pathogenic bacteria. Genetics of sputum gene expression in chronic obstructive pulmonary disease. Qiu et al. 2011. PLoS One. 6(9):e24395. PMID: 21949713. Zebhauser et al. 2005. Genomics. 86(5):566-80. PMID: 16139472. Identification of a novel group of evolutionarily conserved members within the rapidly diverging murine Cea family. Fukuda, I., Yamakado, M. & Kiyose, H. Journal of Medical Systems (1998) 22: 89. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.